Stoke Therapeutics Financial Health

Short Term Liabilities: STOK's short term assets ($264.6M) exceed its short term liabilities ($28.8M).

Long Term Liabilities: STOK's short term assets ($264.6M) exceed its long term liabilities ($44.7M).

Debt Level: STOK is debt free.

Reducing Debt: STOK has not had any debt for past 5 years.

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: STOK has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: STOK has sufficient cash runway for 2 years if free cash flow continues to reduce at historical rates of 20.9% each year.

• Healthy companies in the Pharmaceuticals & Biotech industry.